Efficacy of Minodronate with Eldecalcitol (MIN/ELD) and Denosumab after 2-year Teriparatide treatment in osteoporosis in subjects with rheumatoid arthritis.

Trial Profile

Efficacy of Minodronate with Eldecalcitol (MIN/ELD) and Denosumab after 2-year Teriparatide treatment in osteoporosis in subjects with rheumatoid arthritis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Denosumab (Primary) ; Eldecalcitol (Primary) ; Minodronic acid (Primary)
  • Indications Osteoporosis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top